Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Varigen Biosciences in March, 2022 for $174,652.0 USD from the U.S. Department of Agriculture. | SBIR | 2022-01192 | Phase I | 174,652 | March 30, 2022 | |||||||
A SBIR Phase I contract was awarded to Varigen Biosciences in August, 2021 for $399,846.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43HG012181-01 | Phase I | 399,846 | August 10, 2021 | |||||||
A SBIR Phase I contract was awarded to Varigen Biosciences in August, 2018 for $280,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43HG010125-01 | Phase I | 280,000 | August 1, 2018 | |||||||
A SBIR Phase I contract was awarded to Varigen Biosciences in May, 2017 for $224,326.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM123838-01 | Phase I | 224,326 | May 1, 2017 | |||||||
A SBIR Phase I contract was awarded to Varigen Biosciences in December, 2016 for $225,000.0 USD from the National Science Foundation. | SBIR | 1647958 | Phase I | 225,000 | December 15, 2016 | |||||||
A SBIR Phase I contract was awarded to Varigen Biosciences in September, 2023 for $295,306.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AT012434-01A1 | Phase I | 295,306 | September 5, 2023 | |||||||
A SBIR Phase I contract was awarded to Varigen Biosciences in March, 2023 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI174407-01 | Phase I | 300,000 | March 15, 2023 |